Horst E. Gerlach
Viernheim, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Pain and Health Related Quality of Life in Patients with Superficial Vein Thrombosis: A Post Hoc Analysis of the Multicentre INSIGHTS-SVT Study.
Journal: European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
Published: May 27, 2025
Varicose vein surgery after acute isolated superficial vein thrombosis in daily practice: INSIGHTS-SVT study.
Journal: Journal of vascular surgery. Venous and lymphatic disorders
Published: January 10, 2024
Determinants of Late Venous Thromboembolic Events After Acute Isolated Superficial Vein Thrombosis in Daily Practice: 12 Month Results of the INSIGHTS-SVT Study.
Journal: European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
Published: December 14, 2022
Clinical outcomes of cancer-associated isolated superficial vein thrombosis in daily practice.
Journal: Thrombosis research
Published: September 08, 2022
Management and Outcomes of Patients with Isolated Superficial Vein Thrombosis under Real Life Conditions (INSIGHTS-SVT).
Journal: European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
Published: September 10, 2020
Evaluation of direct oral anticoagulants in superficial-vein thrombosis - Authors' reply.
Journal: The Lancet. Haematology
Published: April 10, 2017
Rationale, design, and methodology of the observational INSIGHTS-SVT study on the current state of care and outcomes of patients with superficial vein thrombosis.
Journal: Journal of vascular surgery. Venous and lymphatic disorders
Published: February 02, 2017
Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial.
Journal: The Lancet. Haematology
Published: January 04, 2017
Superficial vein thrombosis treated for 45 days with rivaroxaban versus fondaparinux: rationale and design of the SURPRISE trial.
Journal: Journal of thrombosis and thrombolysis
Published: March 15, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026